Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.
| Stock | Insider | Value | Type | |||
|---|---|---|---|---|---|---|
| CRBGCorebridge Financial, Inc. | Nippon Life Insurance Co10% Owner | $6.39M | Added | |||
| 182,826 shares at $34.9529 weighted avg (range $34.58–$35.31). Ongoing 10b5-1 plan purchase adopted Aug 7, 2026. Trade date Oct 26. | ||||||
| GOLDGold.com, Inc. | Giancarlo Devasini10% Owner | $3.93M | Added | |||
| Three tranches: 32,675 @ $38.96 (Oct 26), 39,692 @ $39.44 (Oct 27), 27,633 @ $39.39 (Oct 28). Purchased via Tether Global Investments Fund. Post-transaction position: ~3.87M shares. | ||||||
| ACNAccenture PLC | Julie Spellman SweetChair and CEO | $3.00M | Added | |||
| Two tranches on Oct 26: 2,100 @ $245.11 + 10,100 @ $246.17. Open-market purchase. CEO now holds 48,910 shares directly. | ||||||
| BPREBluerock Private Real Estate Fund | Ramin KamfarDirector | $2.23M | Added | |||
| Two tranches: 109,019 @ $12.477 (Oct 26) + 69,658 @ $12.483 (Oct 27). Purchased via Bluerock Asset Management, LLC (controlled entity). Founder/director accumulation. | ||||||
| TTMITTM Technologies Inc | Ali WajidDirector | $902K | Added | |||
| Two equal tranches on Oct 28: 5,000 @ $89.857 + 5,000 @ $90.635. Same-day cluster with CEO Roks. Post-transaction: 35,835 shares. | ||||||
| XBITXBiotech Inc. | John SimardDirector, 10% Owner | $711K | Added | |||
| Purchased Oct 26 at $1.93 per share from Thorpe McKenzie (private block transfer, still code P). Post-transaction: 4,191,690 shares. | ||||||
| TTMITTM Technologies Inc | Edwin RoksPresident and CEO | $440K | Added | |||
| 5,000 shares at $88.07 on Oct 28. Cluster buy — same day as Director Wajid. Post-transaction: 64,483 shares directly. | ||||||
| HBANHuntington Bancshares Inc | James D. Rollins IIIDirector | $254K | Added | |||
| Preferred stock purchases on Oct 26: 4,000 Ser H @ $14.855 + 10,000 Ser I @ $19.43 (wtd avg $19.30–$19.45). HBAN common at $15.70. Director buying preferred tranches, not common. | ||||||
Scanned the last 24 hours of EDGAR Form 4 filings (Oct 28–29, 2026). 8 qualifying buys (≥ $250K, transaction type P) totalling ~$17.9M.
TTMI cluster buy is the most actionable signal today: CEO Edwin Roks AND Director Ali Wajid both purchased on October 28 in the open market — a same-day cluster from two distinct insiders. Roks's buy was at a lower $88.07 avg (possibly early session) vs. Wajid's $90.25 avg. Both are already in the green at $90.79.
ACN CEO purchase: Julie Sweet's $3M open-market buy in Accenture comes after the stock has pulled back from recent highs, and she is slightly underwater at current $243.40 vs. her $246.02 avg cost. CEO conviction buys from mega-cap executives on pullbacks tend to carry signal.
CRBG: Nippon Life's steady drip via a 10b5-1 plan (adopted Aug 7) continues — this is the second consecutive week with a $6M+ filing. Less signal value as discretionary buys, but indicates institutional conviction in Corebridge's valuation at $34–35.
GOLD (Gold.com / Tether): Giancarlo Devasini, CFO of Tether, used Tether's investment vehicle to buy across three days at consistent prices ($38.96–$39.44). The position now sits at 3,870,787 shares. This is a strategic accumulation, not a one-off.
XBIT: John Simard's block purchase was bought "from Thorpe McKenzie" — a private transfer from another institutional holder, not exchange-sourced. Still counts as a P transaction and reflects insider conviction at distressed micro-cap levels.
HBAN preferred is an unusual insider buy: Rollins purchased Series H and Series I perpetual preferred, not common. This type of preferred-share purchase by a director suggests comfort with the bank's credit profile and income yield rather than equity upside.
Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.
SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free, and a new scan is posted every trading day. How to read insider buying →
See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.
Open the live chartOpen in the Stocks tab© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.